US68375N1037 - Common Stock
OPKO HEALTH INC
NASDAQ:OPK (9/16/2024, 8:00:02 PM)
Premarket: 1.62 -0.02 (-1.22%)1.64
+0.07 (+4.46%)
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 3,930 full-time employees. The firm's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). The company has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. The company develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.
OPKO HEALTH INC
4400 Biscayne Blvd.
Miami FLORIDA 33137
P: 13055754181
CEO: Phillip Frost
Employees: 3930
Website: https://www.opko.com/
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational...
Curious about the stocks that are showing activity after the closing bell on Thursday?
OPK earnings call for the period ending June 30, 2024.
Conference call begins at 4:30 p.m. Eastern time today...
Here you can normally see the latest stock twits on OPK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: